Medicalization of women's sexual problems: A different story?

Journal of Sex and Marital Therapy

Volumn 33, Issue 5, 2007, Pages 443-447

  Graham, Cynthia A ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL; TADALAFIL; TESTOSTERONE; VARDENAFIL;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUSTRY; ERECTILE DYSFUNCTION; FEMALE SEXUAL DYSFUNCTION; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; REVIEW; SEXUALITY; TREATMENT OUTCOME;

EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; RESEARCH DESIGN; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE; TREATMENT OUTCOME; UNITED STATES; WOMEN'S HEALTH;

EID: 34547657684     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/00926230701480307     Document Type: Review

References (25)

1. Anstett, P. (2007). Medicare limits coverage for Viagra. Seattle Times, January 27.
2. Bancroft, J. (2002). The medicalization of female sexual dysfunction: The need for caution. Archives of Sexual Behavior, 31, 451-455.
3. Bancroft, J., Graham, C. A., & McCord, C. (2001). Conceptualizing sexual problems in women. Journal of Sex & Marital Therapy, 27, 95-103.
4. Bancroft, J., Loftus, J., & Long, J. S. (2003). Distress about sex: A national survey of women in heterosexual relationships. Archives of Sexual Behavior, 32, 193-208.
5. Basson, R., Berman, J., Burnett, A., Derogatis, L., Ferguson, D., Fourcroy, J., Goldstein, I., Graziottin, A., Heiman, J., Laan, E., Leiblum, S., Padma-Nathan, H., Rosen, R., Segraves, K., Segraves, R. T., Shabsigh, R., Sipski, M., Wagner, G., & Whipple, B. (2000). Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and classification. The Journal of Urology, 163, 888-893.
6. Basson, R., McInnes, R., Smith, M. D., Hodgson, G., & Koppiker, N. (2002). Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. Journal of Women's Health and Gender-Based Medicine, 11, 367-377.
7. Bergeron, S., Binik, Y. M., Khalifé, S., Pagidas, K., Glazer, H. I., Meana, M., & Amsel, R. (2001). A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain, 91, 297-306.
8. Binik, Y. M., Bergeron, S., & Khalifé, S. (2007). Dyspareunia and vaginismus: Socalled sexual pain. In S. R. Leiblum (Ed.), Principles and practice of sex therapy, 4th ed. New York: Guilford Press.
9. Dennerstein, L., Lehert, P., Burger, H., & Dudley, E. (1999). Factors affecting sexual functioning of women in the midlife years. Climacteric, 2, 254-262.
10. Ellison, C. (2000). Women's sexualities. Oakland, CA: New Harbinger.
11. Enserink, M. (2005). Let's talk about sex-and drugs. Science, 308, 1578-1580.
12. Fishman, J. R. (2004). Manufacturing desire: The comodification of female sexual dysfunction. Social Studies of Science, 34, 187-218.
13. Graham, C. A., Sanders, S. A., Milhausen, R., & McBride, K. (2004). Turning on and turning off: A focus group study of the factors that affect women's sexual arousal. Archives of Sexual Behavior, 33, 527-538.
14. Harris, G. (2004). Pfizer gives up testing Viagra on women. New York Times, February 28.
15. Laumann, E. O., Paik, A., & Rosen, R. C. (1999). Sexual dysfunction in the United States: Prevalence and predictors. Journal of the American Medical Association, 281, 537-544.
16. Mercer, C. H., Fenton, K. A., Johnson, A. M., Wellings, K., MacDowell, W., McManus, S., Nanchahal, K., & Erens, B. (2003). Sexual function problems and help seeking behaviour in Britain: National probability sample survey. British Medical Journal, 327, 426-427.
17. Moynihan, R. (2003). The making of a disease: Female sexual dysfunction. British Medical Journal, 326, 45-47.
18. Moynihan, R. (2005). The marketing of a disease: Female sexual dysfunction. British Medical Journal, 330, 192-194.
19. Potts, A., Gavey, N., Grace, V. M., & Vares, T. (2003). The downside of Viagra: Women's experiences and concerns. Sociology of Health & Illness, 25, 697-719.
20. Reissing, E. D., Binik, Y. M., Khalifé, S., Cohen, D., & Amsel, R. (2003). Etiological correlates of vaginismum: Sexual and physical abuse, sexual knowledge, sexual self-schema, and relationship adjustment. Journal of Sex & Marital Therapy, 29, 47-59.
21. Rowland, D. L. (2007). Will medical solutions to sexual problems make sexological care and science obsolete? Journal of Sex & Marital Therapy, 33, 385-397.
22. Souverein, P. C., Egberts, A. C. G., Meuleman, E. J. H., Urquhart, J., & Leufkens, H. G. M. (2002). Incidence and determinants of sildenafil (dis)continuation: The Dutch cohort of sildenafil users. International Journal of Impotence Research, 14, 259-265.
23. The Working Group for a New View of Women's Sexual Problems. (2001). A new view of women's sexual problems. In E. Kaschak & L. Tiefer (Eds.), A new view of women's sexual problems (pp. 1-8). New York: The Haworth Press.
24. Tiefer, L. (2001). A new view of women's sexual problems: Why new? Why now? The Journal of Sex Research, 38, 89-96.
25. Tomlinson, J., & Wright, D. (2004). Impact of erectile dysfunction and its subsequent treatment. British Medical Journal, 328, 1037-1039.